• 1
    Finkelstein FO, Shirani S, Wuerth D, Hinkelstein SH. Therapy insight: Sexual dysfunction in patients with chronic kidney disease. Nephrology 2007;3:2007.
  • 2
    Absher JR, Vogt BA, Clark DG, Flowers DL, Gormon DG, Keyes JW, Wood FB. Hypersexuality and hemiballism due to subthalamic infarction. Neuropsychiatry Neuropsychol Behav Neurol 2000;13:2209.
  • 3
    Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet 2007;369:51225.
  • 4
    Doumas M, Douma S. Sexual dysfunction in essential hypertension: Myth or reality? J Clin Hypertens 2006;8:26974.
  • 5
    Tsortis V, Skriapas K, Hadjigeorgiou G, Mitsogiannis I, Aggelakis K, Gravas S, Poulakis V, Melekos MD. Sexual dysfunction in newly diagnosed multiple sclerosis women. Mult Scler 2008;14:5613.
  • 6
    Penson D, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: Results from the prostate cancer outcomes study. J Urol 2005;173:17015.
  • 7
    Bergmark K, Avall-Lundqvist E, Dickman PW, Henningoshn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 1999;340:13839.
  • 8
    Likes MW, Stegbuaer C, Tillmanns T, Purelt J. Pilot study of sexual function and quality of life after excision for vulvar intraephithelial neoplasia. J Reprod Med 2007;52:2330.
  • 9
    Incrocci L. Sexual function after external-beam radiotherapy for prostate cancer: What do we know? Crit Rev Oncol Hematol 2006;57:16573.
  • 10
    Bruner DW, Lanciano R, Keegan M. Vaginal stenosis and sexual dysfunction following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys 1993;27:82530.
  • 11
    Kornblith AB, Ligibel J. Psychological and sexual functioning of survivors of breast cancer. Semin Oncol 2003;30:799813.
  • 12
    Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR. Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood 2008;111:98996.
  • 13
    Basaria S, Lieb J 2nd, Tang AM, DeWeese T, Carduccit M, Eisenberger M, Dobs AS. Long-term effects of androgen deprivation therapy in prostrate cancer patients. Clin Endocrinol 2002;56:77986.
  • 14
    Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Quality of life of postmenopausal women in the arimidex, tamoxifen alone or in combination (ATAC) adjunct breast cancer trial. J Clin Oncol 2004;22:426171.
  • 15
    Hallinan R, Byrne A, Ago K, McMahon C, Tynan P, Attia J. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med 2008;5:68492.
  • 16
    Clayton A, Kornstein S, Prakash A, Mallinckordt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007;4:91729.
  • 17
    Peng YS, Chiang CK, Kao TW, Hung KY, Lu CS, Chiang SS, Yang CS, Huang YC, Wu KD, Wu MS, Lien YR, Yang CC, Tsai DM, Chen PY, Liao CS, Tsai TJ, Chen WY. Sexual dysfunction in female hemodialysis patients: A multicenter study. Kidney Int 2005;68:7605.
  • 18
    Zivadinov R, Zorzon M, Bosco A, Bragagin LM, Moretti R, Bongigli L, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: Correlation analysis. Mult Scler 1999;5:42831.
  • 19
    Korfage IJ, Pluijm S, Roobol M, Dohle GR, Schroder FH, Essinkbot ML. Erectile dysfunction and mental health in a general population of older men. J Sex Med 2009;6:50512.
  • 20
    Ponsford J. Sexual changes associated with traumatic brain injury. Neuropsychol Rehabil 2003;13:27589.
  • 21
    Hibbard MR, Gordon WA, Flanagan S, Haddad L, Labinsky E. Sexual dysfunction after traumatic brain injury. NeuroRehabilitation 2000;15:10720.
  • 22
    Glass C, Soni B. ABC of sexual health: Sexual problems of disabled patients. BMJ 1999;318:51821.
  • 23
    Bhasin S, Cunningham G, Hayes F, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:19952010.
  • 24
    Anderson KD, Borisoff JF, Johnson RD, Elliott SL. Long-term effects of spinal cord injury on sexual function in men: Implications for neuroplasticity. Spinal Cord 2007;45:33848.
  • 25
    Giuliano F, Hultling C, El Masri WS, Smith MD, Osterloh IH, Orr M, Mayto M. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group. Ann Neurol 1999;46:1521.
  • 26
    Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elio-Mboussa A, Cassariego J. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol 2007;64:158492.
  • 27
    Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wachs BH. Vardenafil improved ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury. Spine 2008;33:70915.
  • 28
    Soler JM, Previnaire JG, Plante P, Denys P, Chartier-Kastler E. Midodrine improves ejaculation in spinal cord injured men. J Urol 2007;178:20826.
  • 29
    Sipski ML, Rosen RC, Alexander CJ, Hamer RM. Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology 2000;55:8125.
  • 30
    Lundberg PO. Sexual dysfunction in female patients with multiple sclerosis. Int Rehabil Med 1981;3:324.
  • 31
    Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ, Sweeney M. A double blind, randomized study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:7005.
  • 32
    Hirsch IH, SMith RL, Chancellor MB, Bagley DH, Carsello J, Staas WE Jr. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Paraplegia 1994;32:6614.
  • 33
    Dasgupta R, Wiseman OJ, Kanabar G, Fowler CJ, Mikol DD. Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J Urol 2004;171:118993.
  • 34
    Kimura M, Murata Y, Shimoda K, Robinson RG. Sexual dysfunction following stroke. Compr Psychiatry 2001;42:21722.
  • 35
    Tamam Y, Tamam L, Akil E, Yasan A, Tamam B. Post-stroke sexual dysfunction in first stroke patients. Eur J Neurol 2008;15:6606.
  • 36
    Hawton K. Sexual adjustment of men who have had strokes. J Psychosom Res 1984;28:2439.
  • 37
    Jacobs H, Vieregge A, Vieregge P. Sexuality in young patients with Parkinson's disease: A population based comparison with healthy controls. J Neurol Neurosurg Psychiatry 2000;69:5502.
  • 38
    Welsh M, Hung L, Waters CH. Sexuality in women with Parkinson's disease. Mov Disord 1997;12:9237.
  • 39
    Meco G, Rubino A, Caravona N, Valente M. Sexual dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2008;14:4516.
  • 40
    Hussain IF, Brady C, Swinn MJ, Mathias C, Fowler CJ. Treatment with sildenafil citrate (Viagra) of erectile dysfunction in parkinsonism due to Parkinson's disease or multiple system atrophy and the risk of exacerbating orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001;71:3714.
  • 41
    Heaton J, Morales A, Adams M, Johnston B, El-Rashidy R. Recovery of erectile dysfunction by the oral administration of apomorphine. Urology 1995;45:2006.
  • 42
    Castelli L, Perozzo P, Genesia ML, Torre E, Pesare M, Cinquepalmi A, Lanotte M, Bergamasco B, Lopiano L. Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 2004;75:12604.
  • 43
    Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patient with Parkinson's disease: The role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 2007;21:5006.
  • 44
    Herzog AG, Drislane FW, Schomer DL, Pennell PB, Bromfield EB, Dworetzky BA, Farina EL, Frye CA. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 2005;65:101620.
  • 45
    Harden CL. Sexual function in women with epilepsy. Seizure 2008;17:1315.
  • 46
    Devinsky O. Neurologist-induced sexual dysfunction. Enzyme-inducing antiepileptic drugs. Neurology 2005;65:9801.
  • 47
    Herzog AG, Klein P, Jacobs AR. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology 1998;50:7824.
  • 48
    Herrmann BL, Rehder J, Kahlke S, Wiedemayer H, Doerfler A, Ischebeck W, Laumer R, Forsting M, Stolke D, Mann K. Hypopituitarism following severe traumatic brain injury. Exp Clin Endocrinol Diabetes 2006;114:31621.
  • 49
    Kelly DF, McArthur DL, Levin H, Swimmer S, Dusick JR, Cohan P, Wang C, Swerdloff R. Neurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, moderate, or severe traumatic brain injury. J Neurotrauma 2006;23:92842.
  • 50
    Betts T. Managing epilepsy with women in mind. London & New York: Taylor & Francis; 2005.
  • 51
    Baird AD, Wilson SJ, Bladin PF, Saling MM, Reutens DC. The amygdala and sexual drive: Insights from temporal lobe epilepsy surgery. Ann Neurol 2004;55:8796.
  • 52
    Diemont WL, Vruggink PA, Meuleman EJH, Doesburg WH, Lemmens WA, Berden JH. Sexual dysfunction after renal replacement therapy. Am J Kidney Dis 2000;35:84551.
  • 53
    Musone D, Cindolo L, Altieri V, Russo D. Erectile dysfunction in kidney transplanted patients. Minerva Urol Nefrol 2003;655:1937.
  • 54
    Rosas SE, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, Grossman E, Glasser D, Feldman H. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 2001;59:225966.
  • 55
    Lawrence IG, Price DE, Howlett TA, Harris KP, Feehally J, Walls J. Erythropoietin and sexual dysfunction. Nephrol Dial Transplant 1997;12:7417.
  • 56
    Wu SC, Lin SL, Jeng FR. Influence of erythropoietin treatment of gonadotropic hormone levels and sexual function in male uremic patients. Scand J Urol Nephrol 2001;35:13640.
  • 57
    Vaziri ND, Ni Z, Oveisi F, Ling K, Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002;39:13541.
  • 58
    Sáenz de Tejada I, Angulo J, Cellek S, Gonzales-Cadavid N, Heaton J, Pickard R, Simonsen U. Pathophysiology of erectile dysfunction J Sex Med 2005;2:2639.
  • 59
    Russo D, Musone D, Alteri V, Cindolo L, Lanzillo B, Federico S, Andreucci VE. Erectile dysfunction in kidney transplanted patients, efficacy of sildenafil. J Nephrol 2004;17:291.
  • 60
    Bita G, Beolinghieri G, Trusso A, Costantino G, Santoro D, Monteleone F, Messina C, Savica V. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 1999;56:2327.
  • 61
    Mahon A, Sidhu PS, Muir G, Macdougall IC. The efficacy of sildenafil for the treatment of erectile dysfunction in male peritoneal dialysis patients. Am J Kidney Dis 2005;45:3817.
  • 62
    Sharma RK, Prasad N, Gupta A, Kapoor R. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: A randomized, double-blind, placebo-controlled, crossover trial. Am J Kidney Dis 2006;48:12833.
  • 63
    Lasaponara F, Paradiso M, Milan MGL, Morabito F, Sedigh O, Graziano ME, Abbona A, Piccoli GB, Rossetti M, Mezza E, Ferrando U. Erectile dysfunction after kidney transplantation: Our 22 years of experience. Transplant Proc 2004;36:5024.
  • 64
    Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: Results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001;15:1623163.
  • 65
    Soykan A, Boztas H, Kutlay S, Ince E, Nergizoglu G, Dileköz, Berksun O. Do sexual dysfunctions get better during dialysis? Results of a six-month prospective follow-up study from Turkey. Int J Impot Res 2005;17:35963.
  • 66
    San-Chiang W, Sho-Lin L, Fu-Rong J. Influence of erythropoietin treatment on gonadotropic hormone levels on sexual function in male uremic patients. Scand J Urol Nephrol 2001;35:13640.
  • 67
    Johansen KL. Treatment of hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Dis 2004;4:34856.
  • 68
    Peng YS, Chiang CK, Hung KY, Chiang SS, Lu CS, Yang CS, Wu KD, Yang CC, Lin RP, Chang CJ, Tsai TJ, Chen WY. The association of higher depressive symptoms and sexual dysfunction in male haemodialysis patients. Nephrol Dial Transplant 2007;22:85761.
  • 69
    Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DJ, Peterson RA, Switzer GE. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol 2005;16:248794.
  • 70
    Ozdemir C, Erylmaz M, Yurtman F, Karaman T. Sexual functioning after renal transplantation. Transplant Proc 2007;39:14514.
  • 71
    Matuszkiewicz-Rowinska J, Skorzewska K, Radowicki S, Sokalski A, Przedlacki J, Niemczyk S, Wlodarczyk D, Puka J, Switalski M. The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis. Nephrol Dial Transplant 1999;14:123842.
  • 72
    Kettas E, Çayan F, Akbay E, Kiykim A, Çayan S. Sexual dysfunction and associated risk factors in women with end-stage renal disease. J Sex Med 2008;5:8727.
  • 73
    Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomized controlled trial. JAMA 2008;300:395404.
  • 74
    Caruso S, Rugolo S, Agnello C, Intelisano G, Di Mari L, Cianci A. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: A double-blind, crossover, placebo-controlled pilot study. Fertil Steril 2006;85:1496501.
  • 75
    Toorians AWFT, Janssen E, Laan E, Gooren LJG, Giltay EJ, Oe PL, Donker AJM, Everaerd W. Chronic renal failure and sexual functioning: Clinical status versus objectively assessed sexual response. Nephrol Dial Transplant 1997;12:265463.
  • 76
    Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol 1999;19:13818.
  • 77
    Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la disfuncion Erectil Masculina Study. J Urol 2001;166:56975.
  • 78
    Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: Co-morbidity or typical “Aging Male” symptoms? Results of the “Cologne Male Survey. Eur Urol 2003;44:58894.
  • 79
    Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade R, Kiemeney L, Lee C. The association between lower urinary tract symptoms and erectile dysfunction in four centres: The UrEpik study. BJU Int 2003;92:71925.
  • 80
    Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary MP, Puppo P, Robertson C, Giuliano F. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:63749.
  • 81
    Vallancien G, Emberton M, Harving N, Van Moorselaar RJ, Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003;169:225761.
  • 82
    Li MK, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: A survey of aging men from five Asian countries. BJU Int 2005;96:133954.
  • 83
    Shiri R, Häkkinen J, Koskimäki J, Hakama M, Tammela TL, Auvinen A. Erectile dysfunction influences the subsequest incidence of lower urinary tract symptoms and bother. Int J Impot Res 2007;19:31720.
  • 84
    Antunes AA, Srougi M, Dall'oglio MF, Vicentini F, Paranhos M, Freire GC. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening. J Sex Med 2008;5:17027.
  • 85
    Mondul AM, Rimm EB, Giovannucci E, Glasser DB, Platz EA. A prospective study of lower urinary tract symptoms and erectile dysfunction. J Urol 2008;179:23216.
  • 86
    Rhoden EL, Riedner CE, Fornari A, Fuchs SC, Ribeiro EP. Evaluation of the association between lower urinary tract symptoms and erectile dysfunction, considering its multiple risk factors. J Sex Med 2008;5:2002668.
  • 87
    Taylor JM, DeSouza R, Wang R. Common approach to managing lower urinary tract symptoms and erectile dysfunction. Asian J Androl 2008;10:4553.
  • 88
    AUA Guideline on the Management of Benign Prostatic Hyperplasia, Chapter 3. 2003.
  • 89
    Elhilali M, Emberton M, Matzkin H, Van Moorselaar RJ, Hartung R, Harving N, Alcaraz A, Vallancien G. Long-term efficacy and safety of alfuzosin 10 mg once daily: A 2-year experience in “real-life” practice. BJU Int 2005;97:5139.
  • 90
    Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU Int 2006;97(2 suppl):348.
  • 91
    Nickel JC, Fradet Y, Boake RC, Pommerville PJ, Perreault JP, Afridi SK, Elhilali MM. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: Results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety plus Efficacy Canadian Two year Study. CMAJ 1996;155:12519.
  • 92
    Andriole GL, Kirby R. Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. Eur Urol 2003;44:828.
  • 93
    Mondaini N, Gontero P, Giubilei G, Lombardi G, Cai T, Gavazzi A, Bartoletti R. Finasteride 5 mg and sexual side effects: How many of these are related to a nocebo phenomenon? J Sex Med 2007;4:170812.
  • 94
    Wessells H, Roy J, Bannow J, Grayhack J, Matsumoto AM, Tenover L, Herlihy R, Fitch W, Labasky R, Auerback S, Parra R, Rajfer J, Culbertson J, Lee M, Bach MA, Waldstreicher J. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology 2003;61:57984.
  • 95
    McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg JM Jr, Clarke HS, Crawford ED, Diolno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:238798.
  • 96
    Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Morrill B, Montorsi F. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol 2008;179:61621.
  • 97
    McVary KT, Monnig W, Camps JL, Young JM, Tseng LJ, Van Den Ende G. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized, double-blind study. J Urol 2007;177:10717.
  • 98
    McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2007;177:14017.
  • 99
    Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E. A randomized, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008;53:123644.
  • 100
    Salonia A, Zanni G, Nappi RE, Briganti A, Doho F, Fabbri F, Colombo R, Guazzoni G, Di Girolamo V, Rigatti P, Montorsi F. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study. Eur Urol 2004;45:6428.
  • 101
    Aslan G, Koseoglu H, Sadik O, Gimen S, Chilan A, Esen A. Sexual function in women with urinary incontinence. Int J Impot Res 2005;17:24851.
  • 102
    Møller LA, Lose G. Sexual activity and lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct 2005;17:1821.
  • 103
    Kim YH, Seo JT, Yoon H. The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women. Int J Impot Res 2005;17:15863.
  • 104
    Özel B, White T, Urwitz-Lane R, Minaglia S. The impact of pelvic organ prolapsed on sexual function in women with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:147.
  • 105
    Sen I, Onaran M, Aksakal N, Acar C, Tan MO, Acar A, Bozkirli I. The impact of urinary incontinence on female sexual function. Adv Ther 2006;23:9991008.
  • 106
    Brading AF, Heaton JP, Hashitani H. A survey of commonalities relevant to function and dysfunction in pelvic and sexual organs. Int J Impot Res 2008;20:116.
  • 107
    Sand PK, Goldberg RP, Dmochowski RR, McIlwain M, Dahl NV. The impact of the overactive bladder syndrome on sexual function: A preliminary report from the multicenter assessment of transdermal therapy in overactive bladder with oxybutynin trial. Am J Obstet Gynecol 2006;195:17305.
  • 108
    Hajebrahimi S, Azaripour A, Sadeghi-Bazargani H. Tolterodine immediate release improves sexual function in women with overactive bladder. J Sex Med 2008;5:28805.
  • 109
    Bø K, Talseth T, Vinsnes A. Randomized controlled trial on the effect of pelvic floor muscle training on quality of life and sexual problems in genuine stress incontinence women. Acta Obstet Gynecol Scand 2000;79:598603.
  • 110
    Beji NK, Yalcin O, Erkan HA. The effect of pelvic floor training on sexual function of treated patients. Int Urogynecol J Pelvic Floor Dysfunct 2003;14:2348.
  • 111
    Giuseppe PG, Pace G, Vicentini C. Sexual function in women with urinary incontinence treated by pelvic floor transvagianl electrical stimulation. J Sex Med 2007;4:7027.
  • 112
    Maaita M, Bhaumik J, Davies AE. Sexual function after using tension-free vaginal tape for the surgical treatment of genuine stress incontinence. BJU Int 2002;90:5403.
  • 113
    Yeni E, Unal D, Verit A, Kafali H, Ciftci H, Gulum M. The effect of tension-free vaginal tape (TVT) procedure on sexual function in women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003;14:3904.
  • 114
    Elzevier HW, Vennema PL, Lycklama A, Nijeholt AA. Sexual function after tension-free vaginal tape (TVT) for stress incontinence: Results of a mailed questionnaire. Int Urogynecol J Pelvic Floor Dysfunct 2004;15:3138.
  • 115
    Mazouni C, Karsenty G, Bretelle F, Bladou F, Gamerre M, Serment G. Urinary complications and sexual function after the tension-free vaginal tape procedure. Acta Obstet Gynecol Scand 2004;83:95561.
  • 116
    Glavind K, Tetsche MS. Sexual function in women before and after suburethral sling operation for stress urinary incontinence: A retrospective questionnaire study. Acta Obstet Gynecol Scand 2004;83:9658.
  • 117
    Ghezzi F, Serati M, Cromi A, Uccella S, Triacca P, Bolis P. Impact of tension-free vaginal tape on sexual function: Results of a prospective study. Int Urogynecol J Pelvic Floor Dysfunct 2005;17:549.
  • 118
    Barber MD, Visco AG, Wymann JF, Fantl JA, Bump RC. Sexual function in women with urinary incontinence and pelvic organ prolaspe. Obstet Gynecol 2002;99:2819.
  • 119
    Helström L, Nilsson B. Impact of vaginal surgery on sexuality and quality of life in women with urinary incontinence or genital descensus. Acta Obstet Gynecol Scand 2005;84:7984.
  • 120
    Novi JM, Jeroni S, Morgan MA, Arya LA. Sexual function in women with pelvic organ prolapsed compared to women without pelvic organ prolapse. J Urol 2005;173:166972.
  • 121
    Casper RC, Redmond DE Jr., Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder: Presence and relationship to the classification of depression. Arch Gen Psychiatry 1985;42:1098104.
  • 122
    Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with different antidepressant agents. A prospective and multicenter study in 1,022 patients. J Clin Psychiatry 2001;62(3 suppl):1021.
  • 123
    Kessler R. Advocacy groups: A cross-national comparison. New Research Program and Abstracts of the 1998 Annual Meeting of the American Psychiatric Association 1998. NR596. p. 228.
  • 124
    Saiz-Ruiz J, Montes JM, Ibáñez A, Díaz M, Vicente F, Pelegrín C, Viñas R, Arias F, Carrasco JL, Ferrando L. Assessment of sexual functioning in depressed patients treated with mirtazapine: A naturalistic 6-month study. Hum Psychopharmacol 2005;20:43540.
  • 125
    Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63:35766.
  • 126
    Rouillon F. Efficacy and tolerance profile of agomelatine and practical use in depressed patients. Int Clin Psychopharmacol 2006;21(1 suppl):S315.
  • 127
    Montgomery SA. Major depressive disorders: Clinical efficacy and tolerability of agomelatine, a new melatonergic agonist. Eur Neuropsychopharmacol 2006;16(5 suppl):S633.
  • 128
    Montejo AL, Prieto N, Terleira A, Matias J, Alonso S, Paniagua G, Naval S, Parra D, Gabriel C, Mocaor F, Portoles A. Better sexual acceptability of agomelatine (25 and 50 mg) compared to paroxetine (20 mg) in healthy male volunteers. A 8-week, placebo controlled study using the PRSexDQ scale J Psychopharmacol 2008 (Epub ahead of print).
  • 129
    Nurnberg HG, Fava M, Gelenberg AJ, Hensley PL, Paine S. Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction. Int J Impot Res 2007;19:16775.
  • 130
    Segraves RT, Lee J, Stevenson R, Walker DJ, Wang WC, Dickson RA. Tadalafil for treatment of erectile dysfunction in men on antidepressants. J Clin Psychopharmacol 2007;27:626.
  • 131
    Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995;56:13741.
  • 132
    Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung WP, Klingmuller D, Lemke MR, Maier W, Schubert M, Strater B, Kuhn KU. Prolactin, subjective well-being and sexual dysfunction: An open label observational study comparing quetiapine with risperidone. J Sex Med 2008;5:281626.
  • 133
    Demyttenaere K, De Fruyt J, Sienaert P. Psychotropics and sexuality. Int Clin Psychopharmacol 1998;13(6 suppl):3541.
  • 134
    Smith S, Mostyn P, Vernals S, O’Keane V, Murray R. A cross sectional survey of sexual dysfunction in patients taking antipsychotic medication. Eur Psychiatry 1998;13(4 suppl):285s.
  • 135
    Uçok A, Incesu C, Aker T, Erkoç S. Sexual dysfunction in patients with schizophrenia on antipsychotic medication. Eur Psychiatry 2007;22:32833.
  • 136
    Westheide J, Cohen S, Bender S, Cooper-Mahkorn D, Erfurth A, Gastpar M, Huber TJ, Maier W, Murafi A, Rothermund M, Signerski J, Sträter B, Teusch L, Weig W, Welling A, Kühn KU. Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication. Pharmacopsychiatry 2007;40:1405.
  • 137
    Lambert M, Haro JM, Novick D, Edgell ET, Kennedy L, Ratcliffe M, Naber D. Olanzapine vs. other antipsychotics in actual out-patient settings: Six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study. Acta Psychiatr Scand 2005;111:23243.
  • 138
    Lare SP, Labbate LA. Sildenafil and erectile dysfunction. Am J Psychiatry 2000;157:20556.
  • 139
    Montejo AL, Rico-Villademoros F, Tafalla M. A 6-month prospective observational study on the effects of quetiapine on sexual functioning. J Clin Psychopharmacol 2005;5:5338.
  • 140
    Montejo AL, Rico Villademoros F. Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther 2008;34:22739.
  • 141
    Montejo AL, Garcia M, Espada M, Rico-Villademoros F, Llorca G, Izquierdo JA; for the Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish working group for the study of psychotropic-related sexual dysfunction. Actas Esp Psiquiatr 2000;28:14150.